7376 - 7400 of 7877 Results
Title
Year
- Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy2012OPENTitle: Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagyJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 10Start Page: 2245End Page: 2262Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/dds040Best OA location URL: https://academic.oup.com/hmg/article-pdf/21/10/2245/17254728/dds040.pdfCitation Count: 254
-
OPENTitle: Anatomy of graft-induced dyskinesias: Circuit remodeling in the parkinsonian striatumJournal Name: Basal GangliaPublisher: Elsevier BVVol: 2Issue #: 1Start Page: 15End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.baga.2012.01.002Best OA location URL: https://europepmc.org/articles/pmc3375918?pdf=renderCitation Count: 13
-
OPENTitle: CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 10Start Page: 690End Page: 695Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318249f683Best OA location URL: https://europepmc.org/articles/pmc3306163?pdf=renderCitation Count: 333
-
OPENTitle: Comparison of enrollees and decliners of Parkinson disease sham surgery trialsJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 4Start Page: 506End Page: 511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24940Best OA location URL: https://europepmc.org/articles/pmc3323770?pdf=renderCitation Count: 14
- Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells2012OPENTitle: Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cellsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms1669Best OA location URL: https://www.nature.com/articles/ncomms1669.pdfCitation Count: 236
-
OPENTitle: The association between Mediterranean diet adherence and Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 6Start Page: 771End Page: 774Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24918Best OA location URL: https://europepmc.org/articles/pmc3349773?pdf=renderCitation Count: 188
- Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease2012OPENTitle: Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's diseaseJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 74Issue #: 2Start Page: 284End Page: 295Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1365-2125.2012.04208.xBest OA location URL: https://europepmc.org/articles/pmc3630748?pdf=renderCitation Count: 42
-
OPENTitle: Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 259Issue #: 9Start Page: 1840End Page: 1847Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-012-6419-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-012-6419-4.pdfCitation Count: 54
-
OPENTitle: Characterization of TAE684 as a potent LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 5Start Page: 1864End Page: 1869Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.01.084Best OA location URL: https://europepmc.org/articles/pmc3433743?pdf=renderCitation Count: 84
-
OPENTitle: "On" state freezing of gait in Parkinson disease: A paradoxical levodopa-induced complicationJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 7Start Page: 454End Page: 457Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182477ec0Best OA location URL: https://europepmc.org/articles/pmc3466608?pdf=renderCitation Count: 192
- Pramipexole-Induced Increased Probabilistic Discounting: Comparison Between a Rodent Model of Parkinson's Disease and Controls2012OPENTitle: Pramipexole-Induced Increased Probabilistic Discounting: Comparison Between a Rodent Model of Parkinson's Disease and ControlsJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 37Issue #: 6Start Page: 1397End Page: 1408Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2011.325Best OA location URL: https://www.nature.com/articles/npp2011325.pdfCitation Count: 72
- TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasis2012OPENTitle: TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasisJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 6Start Page: 1013End Page: 1026Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/cdd.2011.189Best OA location URL: https://www.nature.com/articles/cdd2011189.pdfCitation Count: 77
- Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 22012RESTRICTEDTitle: Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2Journal Name: Biochimica et Biophysica Acta (BBA) - Proteins and ProteomicsPublisher: Elsevier BVVol: 1824Issue #: 3Start Page: 450End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbapap.2011.12.009Citation Count: 24
-
OPENTitle: Selective Small Molecule Inhibition of Poly(ADP-Ribose) Glycohydrolase (PARG)Journal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 7Issue #: 3Start Page: 563End Page: 570Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cb200506tBest OA location URL: https://europepmc.org/articles/pmc3306470?pdf=renderCitation Count: 48
-
OPENTitle: 17α-Ethynyl-androst-5-ene-3β,7β,17Journal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/969418Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/969418.pdfCitation Count: 8
-
OPENTitle: A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/324521Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/324521.pdfCitation Count: 26
- A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease2012OPENTitle: A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/364684Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/364684.pdfCitation Count: 16
- Cognitive Profiles in Parkinson’s Disease and Their Relation to Dementia: A Data-Driven Approach2012OPENTitle: Cognitive Profiles in Parkinson’s Disease and Their Relation to Dementia: A Data-Driven ApproachJournal Name: International Journal of Alzheimer's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/910757Best OA location URL: https://downloads.hindawi.com/journals/ijad/2012/910757.pdfCitation Count: 12
-
OPENTitle: Declining Quality of Life in Parkinson Disease Before and After DiagnosisJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 2Issue #: 2Start Page: 153End Page: 160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-2012-12083Best OA location URL: https://europepmc.org/articles/pmc3744127?pdf=renderCitation Count: 9
-
OPENTitle: Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imagingJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 33Issue #: 1Start Page: 35End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2010.02.006Best OA location URL: https://europepmc.org/articles/pmc2908724?pdf=renderCitation Count: 54
-
RESTRICTEDTitle: Genetic mouse models for understanding LRRK2 biology, pathology and pre-clinical applicationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #:Start Page: S180End Page: S182Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1353-8020(11)70056-6Best OA location URL: https://europepmc.org/articles/pmc3972057?pdf=renderCitation Count: 11
-
OPENTitle: Imaging of microglia in patients with neurodegenerative disordersJournal Name: Frontiers in PharmacologyPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphar.2012.00096Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphar.2012.00096/pdfCitation Count: 108
-
OPENTitle: Importance of the Brain Angiotensin System in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 14Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/860923Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/860923.pdfCitation Count: 28
-
OPENTitle: Interocular Asymmetry of Foveal Thickness in Parkinson DiseaseJournal Name: Journal of OphthalmologyPublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/728457Best OA location URL: https://downloads.hindawi.com/journals/joph/2012/728457.pdfCitation Count: 70
- Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for Treatment2012OPENTitle: Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for TreatmentJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/459321Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/459321.pdfCitation Count: 102